BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Docket Clock//docket-clock.pages.dev//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:FDA comment deadlines & effective dates (Docket Clock) X-PUBLISHED-TTL:PT12H REFRESH-INTERVAL;VALUE=DURATION:PT12H BEGIN:VEVENT UID:2026-16353-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261017 DTEND;VALUE=DATE:20261018 SUMMARY:FDA comments close: Reauthorization of the Generic Drug User Fee A mendments\; Public Meeting\; Request for Comments DESCRIPTION:Notice. Federal Register 2026-16353. Docket FDA-2025-N-0873. D etails: https://docket-clock.pages.dev/doc/2026-16353/ Official: https:// www.federalregister.gov/documents/2026/08/11/2026-16353/reauthorization-o f-the-generic-drug-user-fee-amendments-public-meeting-request-for-comment s URL:https://www.federalregister.gov/documents/2026/08/11/2026-16353/reauth orization-of-the-generic-drug-user-fee-amendments-public-meeting-request- for-comments TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-16837-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261019 DTEND;VALUE=DATE:20261020 SUMMARY:FDA comments close: Determining Whether To Submit an ANDA or a 505 (b)(2) Application\; Draft Guidance for Industry\; Availability DESCRIPTION:Notice. Federal Register 2026-16837. Docket FDA-2017-D-5974. D etails: https://docket-clock.pages.dev/doc/2026-16837/ Official: https:// www.federalregister.gov/documents/2026/08/18/2026-16837/determining-wheth er-to-submit-an-anda-or-a-505b2-application-draft-guidance-for-industry URL:https://www.federalregister.gov/documents/2026/08/18/2026-16837/determ ining-whether-to-submit-an-anda-or-a-505b2-application-draft-guidance-for -industry TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19284-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261021 DTEND;VALUE=DATE:20261022 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Or phan Drugs DESCRIPTION:Notice. Federal Register 2026-19284. Docket FDA-2026-N-3400. D etails: https://docket-clock.pages.dev/doc/2026-19284/ Official: https:// www.federalregister.gov/documents/2026/09/21/2026-19284/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/09/21/2026-19284/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17222-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261023 DTEND;VALUE=DATE:20261024 SUMMARY:FDA comments close: Product-Specific Guidances\; Draft and Revised Draft Guidances for Industry\; Availability DESCRIPTION:Notice. Federal Register 2026-17222. Docket FDA-2007-D-0369. D etails: https://docket-clock.pages.dev/doc/2026-17222/ Official: https:// www.federalregister.gov/documents/2026/08/24/2026-17222/product-specific- guidances-draft-and-revised-draft-guidances-for-industry-availability URL:https://www.federalregister.gov/documents/2026/08/24/2026-17222/produc t-specific-guidances-draft-and-revised-draft-guidances-for-industry-avail ability TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17377-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261026 DTEND;VALUE=DATE:20261027 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Allegations of Regulatory Misconduct Voluntarily Submitted to the Center for Devices and Radiological Health DESCRIPTION:Notice. Federal Register 2026-17377. Docket FDA-2026-N-8482. D etails: https://docket-clock.pages.dev/doc/2026-17377/ Official: https:// www.federalregister.gov/documents/2026/08/26/2026-17377/agency-informatio n-collection-activities-proposed-collection-comment-request-allegations-o f URL:https://www.federalregister.gov/documents/2026/08/26/2026-17377/agency -information-collection-activities-proposed-collection-comment-request-al legations-of TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19656-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261026 DTEND;VALUE=DATE:20261027 SUMMARY:FDA comments close: Food Additives Permitted for Direct Addition t o Food for Human Consumption\; Vitamin D2 Inactive Bakers Yeast DESCRIPTION:Rule. Federal Register 2026-19656. Docket FDA-2021-F-1157. Det ails: https://docket-clock.pages.dev/doc/2026-19656/ Official: https://ww w.federalregister.gov/documents/2026/09/25/2026-19656/food-additives-perm itted-for-direct-addition-to-food-for-human-consumption-vitamin-d2-inacti ve URL:https://www.federalregister.gov/documents/2026/09/25/2026-19656/food-a dditives-permitted-for-direct-addition-to-food-for-human-consumption-vita min-d2-inactive TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-10752-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261026 DTEND;VALUE=DATE:20261027 SUMMARY:FDA comments close: Patient-Focused Drug Development for Nonhealin g Chronic Wounds\; Public Meeting\; Request for Comments DESCRIPTION:Notice. Federal Register 2026-10752. Docket FDA-2026-N-5057. D etails: https://docket-clock.pages.dev/doc/2026-10752/ Official: https:// www.federalregister.gov/documents/2026/05/29/2026-10752/patient-focused-d rug-development-for-nonhealing-chronic-wounds-public-meeting-request-for- comments URL:https://www.federalregister.gov/documents/2026/05/29/2026-10752/patien t-focused-drug-development-for-nonhealing-chronic-wounds-public-meeting-r equest-for-comments TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17598-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261027 DTEND;VALUE=DATE:20261028 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Focus Groups and Interviews as Used by the Food and Drug Administration DESCRIPTION:Notice. Federal Register 2026-17598. Docket FDA-2026-N-8087. D etails: https://docket-clock.pages.dev/doc/2026-17598/ Official: https:// www.federalregister.gov/documents/2026/08/28/2026-17598/agency-informatio n-collection-activities-proposed-collection-comment-request-focus-groups- and URL:https://www.federalregister.gov/documents/2026/08/28/2026-17598/agency -information-collection-activities-proposed-collection-comment-request-fo cus-groups-and TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17599-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261027 DTEND;VALUE=DATE:20261028 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Food Canning Establishment Registrat ion\, Process Filing\, and Recordkeeping for Acidified Foods and Thermall y Processed Low-Acid Foods in Hermetically Sealed Containers DESCRIPTION:Notice. Federal Register 2026-17599. Docket FDA-2026-N-8691. D etails: https://docket-clock.pages.dev/doc/2026-17599/ Official: https:// www.federalregister.gov/documents/2026/08/28/2026-17599/agency-informatio n-collection-activities-proposed-collection-comment-request-food-canning URL:https://www.federalregister.gov/documents/2026/08/28/2026-17599/agency -information-collection-activities-proposed-collection-comment-request-fo od-canning TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17605-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261027 DTEND;VALUE=DATE:20261028 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Qualitative Feedback on Agency Servi ce Delivery DESCRIPTION:Notice. Federal Register 2026-17605. Docket FDA-2026-N-8898. D etails: https://docket-clock.pages.dev/doc/2026-17605/ Official: https:// www.federalregister.gov/documents/2026/08/28/2026-17605/agency-informatio n-collection-activities-proposed-collection-comment-request-qualitative-f eedback-on URL:https://www.federalregister.gov/documents/2026/08/28/2026-17605/agency -information-collection-activities-proposed-collection-comment-request-qu alitative-feedback-on TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19850-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261029 DTEND;VALUE=DATE:20261030 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Su bmission of Petitions: Food Additive\, Color Additive (Including Labeling )\, Submission of Information to a Master File in Support of Petitions\; and Electronic Submission Using Food and Drug Administration Form 3503 DESCRIPTION:Notice. Federal Register 2026-19850. Docket FDA-2026-N-2743. D etails: https://docket-clock.pages.dev/doc/2026-19850/ Official: https:// www.federalregister.gov/documents/2026/09/29/2026-19850/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/09/29/2026-19850/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17675-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261030 DTEND;VALUE=DATE:20261031 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Medical Devices\; Reports of Removal s and Corrections DESCRIPTION:Notice. Federal Register 2026-17675. Docket FDA-2026-N-9349. D etails: https://docket-clock.pages.dev/doc/2026-17675/ Official: https:// www.federalregister.gov/documents/2026/08/31/2026-17675/agency-informatio n-collection-activities-proposed-collection-comment-request-medical-devic es-reports URL:https://www.federalregister.gov/documents/2026/08/31/2026-17675/agency -information-collection-activities-proposed-collection-comment-request-me dical-devices-reports TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17676-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261030 DTEND;VALUE=DATE:20261031 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Registration of Human Drug Compoundi ng Outsourcing Facilities Under the Federal Food\, Drug\, and Cosmetic Ac t and Associated Fees DESCRIPTION:Notice. Federal Register 2026-17676. Docket FDA-2026-N-8690. D etails: https://docket-clock.pages.dev/doc/2026-17676/ Official: https:// www.federalregister.gov/documents/2026/08/31/2026-17676/agency-informatio n-collection-activities-proposed-collection-comment-request-registration- of-human URL:https://www.federalregister.gov/documents/2026/08/31/2026-17676/agency -information-collection-activities-proposed-collection-comment-request-re gistration-of-human TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20085-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261102 DTEND;VALUE=DATE:20261103 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Vo luntary Improvement Program DESCRIPTION:Notice. Federal Register 2026-20085. Docket FDA-2026-N-6876. D etails: https://docket-clock.pages.dev/doc/2026-20085/ Official: https:// www.federalregister.gov/documents/2026/10/01/2026-20085/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/10/01/2026-20085/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18133-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261103 DTEND;VALUE=DATE:20261104 SUMMARY:FDA comments close: Advancing Development of Botanical Drug Produc ts\; Request for Information DESCRIPTION:Notice. Federal Register 2026-18133. Docket FDA-2026-N-9550. D etails: https://docket-clock.pages.dev/doc/2026-18133/ Official: https:// www.federalregister.gov/documents/2026/09/04/2026-18133/advancing-develop ment-of-botanical-drug-products-request-for-information URL:https://www.federalregister.gov/documents/2026/09/04/2026-18133/advanc ing-development-of-botanical-drug-products-request-for-information TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-15887-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261103 DTEND;VALUE=DATE:20261104 SUMMARY:FDA comments close: Establishment of a Quantitative Medicine Innov ation Network: Scope\, Feasibility\, and Opportunities\; Request for Info rmation DESCRIPTION:Notice. Federal Register 2026-15887. Docket FDA-2026-N-7605. D etails: https://docket-clock.pages.dev/doc/2026-15887/ Official: https:// www.federalregister.gov/documents/2026/08/05/2026-15887/establishment-of- a-quantitative-medicine-innovation-network-scope-feasibility-and-opportun ities URL:https://www.federalregister.gov/documents/2026/08/05/2026-15887/establ ishment-of-a-quantitative-medicine-innovation-network-scope-feasibility-a nd-opportunities TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18333-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261109 DTEND;VALUE=DATE:20261110 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Human Cells\, Tissues\, and Cellular and Tissue-Based Products DESCRIPTION:Notice. Federal Register 2026-18333. Docket FDA-2026-N-9638. D etails: https://docket-clock.pages.dev/doc/2026-18333/ Official: https:// www.federalregister.gov/documents/2026/09/09/2026-18333/agency-informatio n-collection-activities-proposed-collection-comment-request-human-cells-t issues-and URL:https://www.federalregister.gov/documents/2026/09/09/2026-18333/agency -information-collection-activities-proposed-collection-comment-request-hu man-cells-tissues-and TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18299-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261109 DTEND;VALUE=DATE:20261110 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Pregnancy Exposure Registry Enrollme nt Project: A Survey of Health Care Providers To Advance Pregnancy Safety Data Collection and Improve Health Communications DESCRIPTION:Notice. Federal Register 2026-18299. Docket FDA-2026-N-8361. D etails: https://docket-clock.pages.dev/doc/2026-18299/ Official: https:// www.federalregister.gov/documents/2026/09/09/2026-18299/agency-informatio n-collection-activities-proposed-collection-comment-request-pregnancy-exp osure URL:https://www.federalregister.gov/documents/2026/09/09/2026-18299/agency -information-collection-activities-proposed-collection-comment-request-pr egnancy-exposure TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20661-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261109 DTEND;VALUE=DATE:20261110 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Ad verse Event Program for Medical Devices: (Medical Product Safety Network (MedSun)) DESCRIPTION:Notice. Federal Register 2026-20661. Docket FDA-2026-N-7129. D etails: https://docket-clock.pages.dev/doc/2026-20661/ Official: https:// www.federalregister.gov/documents/2026/10/08/2026-20661/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/10/08/2026-20661/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20768-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261109 DTEND;VALUE=DATE:20261110 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Bi ologics License Applications\, Procedures and Requirements DESCRIPTION:Notice. Federal Register 2026-20768. Docket FDA-2026-N-6667. D etails: https://docket-clock.pages.dev/doc/2026-20768/ Official: https:// www.federalregister.gov/documents/2026/10/09/2026-20768/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/10/09/2026-20768/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20765-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261109 DTEND;VALUE=DATE:20261110 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Ex panded Access to Investigational Drugs for Treatment Use DESCRIPTION:Notice. Federal Register 2026-20765. Docket FDA-2026-N-7426. D etails: https://docket-clock.pages.dev/doc/2026-20765/ Official: https:// www.federalregister.gov/documents/2026/10/09/2026-20765/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/10/09/2026-20765/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19563-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261109 DTEND;VALUE=DATE:20261110 SUMMARY:FDA comments close: Improving Patient Access to Deceased Donor Isl et Cells and Cell Products\; Request for Information DESCRIPTION:Notice. Federal Register 2026-19563. Docket FDA-2026-N-10738. Details: https://docket-clock.pages.dev/doc/2026-19563/ Official: https:/ /www.federalregister.gov/documents/2026/09/24/2026-19563/improving-patien t-access-to-deceased-donor-islet-cells-and-cell-products-request-for-info rmation URL:https://www.federalregister.gov/documents/2026/09/24/2026-19563/improv ing-patient-access-to-deceased-donor-islet-cells-and-cell-products-reques t-for-information TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18529-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261110 DTEND;VALUE=DATE:20261111 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Medical Device Tracking DESCRIPTION:Notice. Federal Register 2026-18529. Docket FDA-2026-N-9350. D etails: https://docket-clock.pages.dev/doc/2026-18529/ Official: https:// www.federalregister.gov/documents/2026/09/11/2026-18529/agency-informatio n-collection-activities-proposed-collection-comment-request-medical-devic e-tracking URL:https://www.federalregister.gov/documents/2026/09/11/2026-18529/agency -information-collection-activities-proposed-collection-comment-request-me dical-device-tracking TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20980-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261113 DTEND;VALUE=DATE:20261114 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; In fant Formula Requirements DESCRIPTION:Notice. Federal Register 2026-20980. Docket FDA-2026-N-7131. D etails: https://docket-clock.pages.dev/doc/2026-20980/ Official: https:// www.federalregister.gov/documents/2026/10/14/2026-20980/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/10/14/2026-20980/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20990-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261113 DTEND;VALUE=DATE:20261114 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Re quirements for Cosmetic Products DESCRIPTION:Notice. Federal Register 2026-20990. Docket FDA-2026-N-6739. D etails: https://docket-clock.pages.dev/doc/2026-20990/ Official: https:// www.federalregister.gov/documents/2026/10/14/2026-20990/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/10/14/2026-20990/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20981-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261113 DTEND;VALUE=DATE:20261114 SUMMARY:FDA comments close: Agency Information Collection Activities\; Sub mission for Office of Management and Budget Review\; Comment Request\; Vo luntary National Retail Food Regulatory Program Standards DESCRIPTION:Notice. Federal Register 2026-20981. Docket FDA-2026-N-7338. D etails: https://docket-clock.pages.dev/doc/2026-20981/ Official: https:// www.federalregister.gov/documents/2026/10/14/2026-20981/agency-informatio n-collection-activities-submission-for-office-of-management-and-budget-re view URL:https://www.federalregister.gov/documents/2026/10/14/2026-20981/agency -information-collection-activities-submission-for-office-of-management-an d-budget-review TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20979-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261113 DTEND;VALUE=DATE:20261114 SUMMARY:FDA comments close: Food Additives Permitted in Feed and Drinking Water of Animals\; Chromium Propionate DESCRIPTION:Rule. Federal Register 2026-20979. Docket FDA-2026-F-2048. Det ails: https://docket-clock.pages.dev/doc/2026-20979/ Official: https://ww w.federalregister.gov/documents/2026/10/14/2026-20979/food-additives-perm itted-in-feed-and-drinking-water-of-animals-chromium-propionate URL:https://www.federalregister.gov/documents/2026/10/14/2026-20979/food-a dditives-permitted-in-feed-and-drinking-water-of-animals-chromium-propion ate TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18805-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261113 DTEND;VALUE=DATE:20261114 SUMMARY:FDA comments close: Statistical Considerations for the Design of R are Disease Clinical Investigations\; Establishment of a Public Docket\; Request for Information and Comments DESCRIPTION:Notice. Federal Register 2026-18805. Docket FDA-2026-N-10165. Details: https://docket-clock.pages.dev/doc/2026-18805/ Official: https:/ /www.federalregister.gov/documents/2026/09/15/2026-18805/statistical-cons iderations-for-the-design-of-rare-disease-clinical-investigations-establi shment-of-a URL:https://www.federalregister.gov/documents/2026/09/15/2026-18805/statis tical-considerations-for-the-design-of-rare-disease-clinical-investigatio ns-establishment-of-a TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19166-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261117 DTEND;VALUE=DATE:20261118 SUMMARY:FDA comments close: Biosimilar User Fee Act III Future Needs in th e Development of Interchangeable Products Post-Workshop\; Draft Strategy Document DESCRIPTION:Notice. Federal Register 2026-19166. Docket FDA-2025-N-2787. D etails: https://docket-clock.pages.dev/doc/2026-19166/ Official: https:// www.federalregister.gov/documents/2026/09/18/2026-19166/biosimilar-user-f ee-act-iii-future-needs-in-the-development-of-interchangeable-products URL:https://www.federalregister.gov/documents/2026/09/18/2026-19166/biosim ilar-user-fee-act-iii-future-needs-in-the-development-of-interchangeable- products TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19181-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261117 DTEND;VALUE=DATE:20261118 SUMMARY:FDA comments close: Electronic Submission Template for Medical Dev ice Premarket Approval Applications (PMAs)\; Draft Guidance for Industry and Food and Drug Administration Staff\; Availability DESCRIPTION:Notice. Federal Register 2026-19181. Docket FDA-2026-D-9429. D etails: https://docket-clock.pages.dev/doc/2026-19181/ Official: https:// www.federalregister.gov/documents/2026/09/18/2026-19181/electronic-submis sion-template-for-medical-device-premarket-approval-applications-pmas-dra ft URL:https://www.federalregister.gov/documents/2026/09/18/2026-19181/electr onic-submission-template-for-medical-device-premarket-approval-applicatio ns-pmas-draft TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19141-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261117 DTEND;VALUE=DATE:20261118 SUMMARY:FDA comments close: Target Animal Safety Evaluation for Veterinary Monoclonal Antibody Products\; Draft Guidance for Industry\; Availabilit y DESCRIPTION:Notice. Federal Register 2026-19141. Docket FDA-2026-D-7233. D etails: https://docket-clock.pages.dev/doc/2026-19141/ Official: https:// www.federalregister.gov/documents/2026/09/18/2026-19141/target-animal-saf ety-evaluation-for-veterinary-monoclonal-antibody-products-draft-guidance -for URL:https://www.federalregister.gov/documents/2026/09/18/2026-19141/target -animal-safety-evaluation-for-veterinary-monoclonal-antibody-products-dra ft-guidance-for TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-16960-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261118 DTEND;VALUE=DATE:20261119 SUMMARY:FDA comments close: Potency Assessment of Active Immunotherapy Pro ducts\; Draft Guidance for Industry\; Availability DESCRIPTION:Notice. Federal Register 2026-16960. Docket FDA-2026-D-8561. D etails: https://docket-clock.pages.dev/doc/2026-16960/ Official: https:// www.federalregister.gov/documents/2026/08/20/2026-16960/potency-assessmen t-of-active-immunotherapy-products-draft-guidance-for-industry-availabili ty URL:https://www.federalregister.gov/documents/2026/08/20/2026-16960/potenc y-assessment-of-active-immunotherapy-products-draft-guidance-for-industry -availability TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19281-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261120 DTEND;VALUE=DATE:20261121 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 DESCRIPTION:Notice. Federal Register 2026-19281. Docket FDA-2026-N-10033. Details: https://docket-clock.pages.dev/doc/2026-19281/ Official: https:/ /www.federalregister.gov/documents/2026/09/21/2026-19281/agency-informati on-collection-activities-proposed-collection-comment-request-prior-notice -of URL:https://www.federalregister.gov/documents/2026/09/21/2026-19281/agency -information-collection-activities-proposed-collection-comment-request-pr ior-notice-of TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19282-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261120 DTEND;VALUE=DATE:20261121 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; State Petitions for Exemption From P reemption DESCRIPTION:Notice. Federal Register 2026-19282. Docket FDA-2026-N-10430. Details: https://docket-clock.pages.dev/doc/2026-19282/ Official: https:/ /www.federalregister.gov/documents/2026/09/21/2026-19282/agency-informati on-collection-activities-proposed-collection-comment-request-state-petiti ons-for URL:https://www.federalregister.gov/documents/2026/09/21/2026-19282/agency -information-collection-activities-proposed-collection-comment-request-st ate-petitions-for TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19283-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261120 DTEND;VALUE=DATE:20261121 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Temporary Marketing Permit Applicati ons DESCRIPTION:Notice. Federal Register 2026-19283. Docket FDA-2026-N-10363. Details: https://docket-clock.pages.dev/doc/2026-19283/ Official: https:/ /www.federalregister.gov/documents/2026/09/21/2026-19283/agency-informati on-collection-activities-proposed-collection-comment-request-temporary-ma rketing URL:https://www.federalregister.gov/documents/2026/09/21/2026-19283/agency -information-collection-activities-proposed-collection-comment-request-te mporary-marketing TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20427-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261120 DTEND;VALUE=DATE:20261121 SUMMARY:FDA comments close: Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products\; Request for Information DESCRIPTION:Notice. Federal Register 2026-20427. Docket FDA-2026-N-10429. Details: https://docket-clock.pages.dev/doc/2026-20427/ Official: https:/ /www.federalregister.gov/documents/2026/10/06/2026-20427/design-and-safet y-considerations-for-clinical-trials-involving-ibogaine-drug-products-req uest-for URL:https://www.federalregister.gov/documents/2026/10/06/2026-20427/design -and-safety-considerations-for-clinical-trials-involving-ibogaine-drug-pr oducts-request-for TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20721-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261123 DTEND;VALUE=DATE:20261124 SUMMARY:FDA comments close: Requirements for Additional Traceability Recor ds for Certain Foods: Enforcement Policy for Certain Retail Food Establis hments and Restaurants\; Draft Guidance for Industry\; Availability DESCRIPTION:Proposed Rule. Federal Register 2026-20721. Docket FDA-2025-D- 6952. Details: https://docket-clock.pages.dev/doc/2026-20721/ Official: h ttps://www.federalregister.gov/documents/2026/10/09/2026-20721/requiremen ts-for-additional-traceability-records-for-certain-foods-enforcement-poli cy-for-certain URL:https://www.federalregister.gov/documents/2026/10/09/2026-20721/requir ements-for-additional-traceability-records-for-certain-foods-enforcement- policy-for-certain TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19704-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261124 DTEND;VALUE=DATE:20261125 SUMMARY:FDA comments close: Robotically-Assisted Surgical Devices-Premarke t Submissions\; Draft Guidance for Industry and Food and Drug Administrat ion Staff\; Availability DESCRIPTION:Notice. Federal Register 2026-19704. Docket FDA-2026-N-9505. D etails: https://docket-clock.pages.dev/doc/2026-19704/ Official: https:// www.federalregister.gov/documents/2026/09/25/2026-19704/robotically-assis ted-surgical-devices-premarket-submissions-draft-guidance-for-industry-an d-food-and URL:https://www.federalregister.gov/documents/2026/09/25/2026-19704/roboti cally-assisted-surgical-devices-premarket-submissions-draft-guidance-for- industry-and-food-and TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19660-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261125 DTEND;VALUE=DATE:20261126 SUMMARY:FDA comments close: Reauthorization of the Biosimilar User Fee Act \; Public Meeting\; Request for Comments DESCRIPTION:Notice. Federal Register 2026-19660. Docket FDA-2015-N-3326. D etails: https://docket-clock.pages.dev/doc/2026-19660/ Official: https:// www.federalregister.gov/documents/2026/09/25/2026-19660/reauthorization-o f-the-biosimilar-user-fee-act-public-meeting-request-for-comments URL:https://www.federalregister.gov/documents/2026/09/25/2026-19660/reauth orization-of-the-biosimilar-user-fee-act-public-meeting-request-for-comme nts TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17580-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261127 DTEND;VALUE=DATE:20261128 SUMMARY:FDA comments close: Compounding Animal Drugs From Bulk Drug Substa nces: Compounding Under CGMP in Federally-Registered Facilities\; Draft G uidance for Industry\; Availability\; Agency Information Collection Activ ities\; Proposed Collection\; Comment Request DESCRIPTION:Notice. Federal Register 2026-17580. Docket FDA-2018-D-4533. D etails: https://docket-clock.pages.dev/doc/2026-17580/ Official: https:// www.federalregister.gov/documents/2026/08/28/2026-17580/compounding-anima l-drugs-from-bulk-drug-substances-compounding-under-cgmp-in-federally-reg istered URL:https://www.federalregister.gov/documents/2026/08/28/2026-17580/compou nding-animal-drugs-from-bulk-drug-substances-compounding-under-cgmp-in-fe derally-registered TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19849-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261130 DTEND;VALUE=DATE:20261201 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Protection of Human Subjects and Ins titutional Review Boards DESCRIPTION:Notice. Federal Register 2026-19849. Docket FDA-2026-N-10132. Details: https://docket-clock.pages.dev/doc/2026-19849/ Official: https:/ /www.federalregister.gov/documents/2026/09/29/2026-19849/agency-informati on-collection-activities-proposed-collection-comment-request-protection-o f-human URL:https://www.federalregister.gov/documents/2026/09/29/2026-19849/agency -information-collection-activities-proposed-collection-comment-request-pr otection-of-human TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-17961-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261201 DTEND;VALUE=DATE:20261202 SUMMARY:FDA comments close: Pharmacokinetics in Patients With Impaired Hep atic Function: Study Design\, Data Analysis\, and Impact on Dosage\; Draf t Guidance for Industry\; Availability DESCRIPTION:Notice. Federal Register 2026-17961. Docket FDA-2026-D-8693. D etails: https://docket-clock.pages.dev/doc/2026-17961/ Official: https:// www.federalregister.gov/documents/2026/09/02/2026-17961/pharmacokinetics- in-patients-with-impaired-hepatic-function-study-design-data-analysis-and -impact-on URL:https://www.federalregister.gov/documents/2026/09/02/2026-17961/pharma cokinetics-in-patients-with-impaired-hepatic-function-study-design-data-a nalysis-and-impact-on TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20720-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261206 DTEND;VALUE=DATE:20261207 SUMMARY:FDA comments close: Challenges and Solutions in Lot-Level Food Tra ceability\; Public Meeting DESCRIPTION:Notice. Federal Register 2026-20720. Docket FDA-2014-N-0053. D etails: https://docket-clock.pages.dev/doc/2026-20720/ Official: https:// www.federalregister.gov/documents/2026/10/09/2026-20720/challenges-and-so lutions-in-lot-level-food-traceability-public-meeting URL:https://www.federalregister.gov/documents/2026/10/09/2026-20720/challe nges-and-solutions-in-lot-level-food-traceability-public-meeting TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20663-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261207 DTEND;VALUE=DATE:20261208 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Channels of Trade Policy for Commodi ties With Residues of Pesticide Chemicals\, for Which Tolerances Have Bee n Revoked\, Suspended\, or Modified by the Environmental Protection Agenc y Pursuant to Dietary Risk Considerations DESCRIPTION:Notice. Federal Register 2026-20663. Docket FDA-2026-N-10605. Details: https://docket-clock.pages.dev/doc/2026-20663/ Official: https:/ /www.federalregister.gov/documents/2026/10/08/2026-20663/agency-informati on-collection-activities-proposed-collection-comment-request-channels-of- trade URL:https://www.federalregister.gov/documents/2026/10/08/2026-20663/agency -information-collection-activities-proposed-collection-comment-request-ch annels-of-trade TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19349-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261207 DTEND;VALUE=DATE:20261208 SUMMARY:FDA comments close: Nonclinical Testing Terminology DESCRIPTION:Proposed Rule. Federal Register 2026-19349. Docket FDA-2026-N- 5347. Details: https://docket-clock.pages.dev/doc/2026-19349/ Official: h ttps://www.federalregister.gov/documents/2026/09/22/2026-19349/nonclinica l-testing-terminology URL:https://www.federalregister.gov/documents/2026/09/22/2026-19349/noncli nical-testing-terminology TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19350-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261207 DTEND;VALUE=DATE:20261208 SUMMARY:FDA comments close: Nonclinical Testing Terminology DESCRIPTION:Rule. Federal Register 2026-19350. Docket FDA-2026-N-5347. Det ails: https://docket-clock.pages.dev/doc/2026-19350/ Official: https://ww w.federalregister.gov/documents/2026/09/22/2026-19350/nonclinical-testing -terminology URL:https://www.federalregister.gov/documents/2026/09/22/2026-19350/noncli nical-testing-terminology TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20766-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261208 DTEND;VALUE=DATE:20261209 SUMMARY:FDA comments close: Determination of Regulatory Review Period for Purposes of Patent Extension\; MONOFERRIC DESCRIPTION:Notice. Federal Register 2026-20766. Docket FDA-2020-E-1882\, FDA-2020-E-1892. Details: https://docket-clock.pages.dev/doc/2026-20766/ Official: https://www.federalregister.gov/documents/2026/10/09/2026-20766 /determination-of-regulatory-review-period-for-purposes-of-patent-extensi on-monoferric URL:https://www.federalregister.gov/documents/2026/10/09/2026-20766/determ ination-of-regulatory-review-period-for-purposes-of-patent-extension-mono ferric TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-16296-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261209 DTEND;VALUE=DATE:20261210 SUMMARY:FDA comments close: Substances Generally Recognized as Safe DESCRIPTION:Proposed Rule. Federal Register 2026-16296. Docket FDA-2025-N- 3262. Details: https://docket-clock.pages.dev/doc/2026-16296/ Official: h ttps://www.federalregister.gov/documents/2026/08/11/2026-16296/substances -generally-recognized-as-safe URL:https://www.federalregister.gov/documents/2026/08/11/2026-16296/substa nces-generally-recognized-as-safe TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-21142-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261211 DTEND;VALUE=DATE:20261212 SUMMARY:FDA comments close: Fit-for-Purpose Rare Disease Framework Initiat ive\; Public Meeting\; Request for Information and Comments DESCRIPTION:Notice. Federal Register 2026-21142. Docket FDA-2026-N-12214. Details: https://docket-clock.pages.dev/doc/2026-21142/ Official: https:/ /www.federalregister.gov/documents/2026/10/16/2026-21142/fit-for-purpose- rare-disease-framework-initiative-public-meeting-request-for-information- and URL:https://www.federalregister.gov/documents/2026/10/16/2026-21142/fit-fo r-purpose-rare-disease-framework-initiative-public-meeting-request-for-in formation-and TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-13006-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261228 DTEND;VALUE=DATE:20261229 SUMMARY:FDA comments close: Determination of Regulatory Review Period for Purposes of Patent Extension\; VYALEV DESCRIPTION:Notice. Federal Register 2026-13006. Docket FDA-2025-E-0162\, FDA-2025-E-0163\, FDA-2025-E-0164. Details: https://docket-clock.pages.de v/doc/2026-13006/ Official: https://www.federalregister.gov/documents/202 6/06/29/2026-13006/determination-of-regulatory-review-period-for-purposes -of-patent-extension-vyalev URL:https://www.federalregister.gov/documents/2026/06/29/2026-13006/determ ination-of-regulatory-review-period-for-purposes-of-patent-extension-vyal ev TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-01903-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261231 DTEND;VALUE=DATE:20270101 SUMMARY:FDA comments close: FDA Rare Disease Innovation Hub Future Program ming\; Request for Comments DESCRIPTION:Notice. Federal Register 2026-01903. Docket FDA-2026-N-0131. D etails: https://docket-clock.pages.dev/doc/2026-01903/ Official: https:// www.federalregister.gov/documents/2026/01/30/2026-01903/fda-rare-disease- innovation-hub-future-programming-request-for-comments URL:https://www.federalregister.gov/documents/2026/01/30/2026-01903/fda-ra re-disease-innovation-hub-future-programming-request-for-comments TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-16247-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270208 DTEND;VALUE=DATE:20270209 SUMMARY:FDA comments close: Determination of Regulatory Review Period for Purposes of Patent Extension\; BRINSUPRI DESCRIPTION:Notice. Federal Register 2026-16247. Docket FDA-2025-E-5206. D etails: https://docket-clock.pages.dev/doc/2026-16247/ Official: https:// www.federalregister.gov/documents/2026/08/10/2026-16247/determination-of- regulatory-review-period-for-purposes-of-patent-extension-brinsupri URL:https://www.federalregister.gov/documents/2026/08/10/2026-16247/determ ination-of-regulatory-review-period-for-purposes-of-patent-extension-brin supri TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-16246-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270208 DTEND;VALUE=DATE:20270209 SUMMARY:FDA comments close: Determination of Regulatory Review Period for Purposes of Patent Extension\; DAYVIGO DESCRIPTION:Notice. Federal Register 2026-16246. Docket FDA-2025-E-0707. D etails: https://docket-clock.pages.dev/doc/2026-16246/ Official: https:// www.federalregister.gov/documents/2026/08/10/2026-16246/determination-of- regulatory-review-period-for-purposes-of-patent-extension-dayvigo URL:https://www.federalregister.gov/documents/2026/08/10/2026-16246/determ ination-of-regulatory-review-period-for-purposes-of-patent-extension-dayv igo TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18300-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270308 DTEND;VALUE=DATE:20270309 SUMMARY:FDA comments close: Determination of Regulatory Review Period for Purposes of Patent Extension\; ANDEMBRY DESCRIPTION:Notice. Federal Register 2026-18300. Docket FDA-2025-E-3595\, FDA-2025-E-3596. Details: https://docket-clock.pages.dev/doc/2026-18300/ Official: https://www.federalregister.gov/documents/2026/09/09/2026-18300 /determination-of-regulatory-review-period-for-purposes-of-patent-extensi on-andembry URL:https://www.federalregister.gov/documents/2026/09/09/2026-18300/determ ination-of-regulatory-review-period-for-purposes-of-patent-extension-ande mbry TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18297-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270308 DTEND;VALUE=DATE:20270309 SUMMARY:FDA comments close: Determination of Regulatory Review Period for Purposes of Patent Extension\; ANKTIVA DESCRIPTION:Notice. Federal Register 2026-18297. Docket FDA-2024-E-4125\, FDA-2024-E-4128\, FDA-2024-E-4129\, FDA-2024-E-4130\, FDA-2024-E-4131. De tails: https://docket-clock.pages.dev/doc/2026-18297/ Official: https://w ww.federalregister.gov/documents/2026/09/09/2026-18297/determination-of-r egulatory-review-period-for-purposes-of-patent-extension-anktiva URL:https://www.federalregister.gov/documents/2026/09/09/2026-18297/determ ination-of-regulatory-review-period-for-purposes-of-patent-extension-ankt iva TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18298-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270308 DTEND;VALUE=DATE:20270309 SUMMARY:FDA comments close: Determination of Regulatory Review Period for Purposes of Patent Extension\; ANZUPGO DESCRIPTION:Notice. Federal Register 2026-18298. Docket FDA-2025-E-3939. D etails: https://docket-clock.pages.dev/doc/2026-18298/ Official: https:// www.federalregister.gov/documents/2026/09/09/2026-18298/determination-of- regulatory-review-period-for-purposes-of-patent-extension-anzupgo URL:https://www.federalregister.gov/documents/2026/09/09/2026-18298/determ ination-of-regulatory-review-period-for-purposes-of-patent-extension-anzu pgo TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20848-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261214 DTEND;VALUE=DATE:20261215 SUMMARY:FDA effective: Use of Salt Substitutes To Reduce the Sodium Conten t in Standardized Foods DESCRIPTION:Rule. Federal Register 2026-20848. Docket FDA-2022-N-2226. Det ails: https://docket-clock.pages.dev/doc/2026-20848/ Official: https://ww w.federalregister.gov/documents/2026/10/13/2026-20848/use-of-salt-substit utes-to-reduce-the-sodium-content-in-standardized-foods URL:https://www.federalregister.gov/documents/2026/10/13/2026-20848/use-of -salt-substitutes-to-reduce-the-sodium-content-in-standardized-foods TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2025-00830-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270115 DTEND;VALUE=DATE:20270116 SUMMARY:FDA effective: Color Additive Petition From Center for Science in the Public Interest\, et al.\; Request To Revoke Color Additive Listing f or Use of FD&C Red No. 3 in Food and Ingested Drugs DESCRIPTION:Rule. Federal Register 2025-00830. Docket FDA-2023-N-0437. Det ails: https://docket-clock.pages.dev/doc/2025-00830/ Official: https://ww w.federalregister.gov/documents/2025/01/16/2025-00830/color-additive-peti tion-from-center-for-science-in-the-public-interest-et-al-request-to-revo ke-color URL:https://www.federalregister.gov/documents/2025/01/16/2025-00830/color- additive-petition-from-center-for-science-in-the-public-interest-et-al-re quest-to-revoke-color TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-15920-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270115 DTEND;VALUE=DATE:20270116 SUMMARY:FDA effective: Micro-Tracers\, Inc.\; Response to Objections and R equests for a Public Hearing DESCRIPTION:Rule. Federal Register 2026-15920. Docket FDA-2023-N-0437. Det ails: https://docket-clock.pages.dev/doc/2026-15920/ Official: https://ww w.federalregister.gov/documents/2026/08/05/2026-15920/micro-tracers-inc-r esponse-to-objections-and-requests-for-a-public-hearing URL:https://www.federalregister.gov/documents/2026/08/05/2026-15920/micro- tracers-inc-response-to-objections-and-requests-for-a-public-hearing TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19350-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270204 DTEND;VALUE=DATE:20270205 SUMMARY:FDA effective: Nonclinical Testing Terminology DESCRIPTION:Rule. Federal Register 2026-19350. Docket FDA-2026-N-5347. Det ails: https://docket-clock.pages.dev/doc/2026-19350/ Official: https://ww w.federalregister.gov/documents/2026/09/22/2026-19350/nonclinical-testing -terminology URL:https://www.federalregister.gov/documents/2026/09/22/2026-19350/noncli nical-testing-terminology TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-15339-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270930 DTEND;VALUE=DATE:20271001 SUMMARY:FDA effective: Animal Drug User Fee Rates and Payment Procedures f or Fiscal Year 2027 DESCRIPTION:Notice. Federal Register 2026-15339. Docket FDA-2026-N-7558. D etails: https://docket-clock.pages.dev/doc/2026-15339/ Official: https:// www.federalregister.gov/documents/2026/07/30/2026-15339/animal-drug-user- fee-rates-and-payment-procedures-for-fiscal-year-2027 URL:https://www.federalregister.gov/documents/2026/07/30/2026-15339/animal -drug-user-fee-rates-and-payment-procedures-for-fiscal-year-2027 TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-15336-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270930 DTEND;VALUE=DATE:20271001 SUMMARY:FDA effective: Food Safety Modernization Act Domestic and Foreign Facility Reinspection\, Recall\, and Importer Reinspection Fee Rates for Fiscal Year 2027 DESCRIPTION:Notice. Federal Register 2026-15336. Docket FDA-2026-N-7896. D etails: https://docket-clock.pages.dev/doc/2026-15336/ Official: https:// www.federalregister.gov/documents/2026/07/30/2026-15336/food-safety-moder nization-act-domestic-and-foreign-facility-reinspection-recall-and-import er URL:https://www.federalregister.gov/documents/2026/07/30/2026-15336/food-s afety-modernization-act-domestic-and-foreign-facility-reinspection-recall -and-importer TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-04368-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20330307 DTEND;VALUE=DATE:20330308 SUMMARY:FDA effective: Revising the National Drug Code Format and Drug Lab el Barcode Requirements DESCRIPTION:Rule. Federal Register 2026-04368. Docket FDA-2021-N-1351. Det ails: https://docket-clock.pages.dev/doc/2026-04368/ Official: https://ww w.federalregister.gov/documents/2026/03/05/2026-04368/revising-the-nation al-drug-code-format-and-drug-label-barcode-requirements URL:https://www.federalregister.gov/documents/2026/03/05/2026-04368/revisi ng-the-national-drug-code-format-and-drug-label-barcode-requirements TRANSP:TRANSPARENT END:VEVENT END:VCALENDAR